Last updated on September 11th, 2021 at 08:02 am
Popular South African pharmaceutical company, Sasol recorded major profit on the JSE in the late hours of Friday, the total profit gained by Sasol was in the excess of over R100 shares which ranks amongst the highest profit gained by the pharmaceutical company.
Sasol shut 8.92 percent higher at R164.99 an offer after it said feature profit an offer would flood by 200 percent to somewhere in the range of R18.59 and R19.78 contrasted with R5.94 in the earlier half year on solid capital and cost the board.
Income per share were relied upon to be somewhere in the range of R22.76 and R24.07 contrasted with the earlier half-year profit per portion of R6.56.
“Sasol is required to convey a solid arrangement of results for the a half year finished December 31, 2020, supported by a solid money cost, working capital and capital consumption execution notwithstanding the impacts of the Covid-19 pandemic.
